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Background: Dorstenia mannii (Moraceae) is a medicinal herb used traditionally for the treatment of many diseases.
In the present study, the methanol extract of D. mannii and nine of its isolated compounds, namely dorsmanin A
(1), B (2), C (3), D (4), E (6), F (7), G (8) dorsmanin I (9) and 6,8-diprenyleriodictyol (5), were tested for their
antimicrobial activities against yeast, Mycobacteria and Gram-negative bacteria.
Methods: The microplate alamar blue assay (MABA) and the broth microdilution method were used to determine
the minimal inhibitory concentration (MIC) and minimal microbicidal concentration (MMC) of the above extract and
compounds on a panel of bacterial species.
Results: The results of the MIC determinations demonstrated that the methanol extract as well as compounds 3
and 8 were able to prevent the growth of all the fourteen studied microorganisms within the concentration range
of 4 to 1024 μg/ml. The lowest MIC value for the methanol extract (64 μg/ml) was obtained on Candida albicans.
The lowest value for individual compounds (4 μg/ml) was recorded with compounds 3 on Pseudomonas aeruginosa
PA01 and 7 on Eschericia coli ATCC strain. The MIC values recorded with compounds 3 on P. aeruginosa PA01, 6 on
C. albicans, 7 on P. aeruginosa PA01 and K. pneumoniae ATCC strain and C. albicans,and 8 on P. aeruginosa PA01,
PA124, P. stuartii, M. tuberculosis MTCS1 were lower than or equal to those of the reference drugs. MMC values not
greater than 1024 μg/ml were recorded on all studied microorganisms with compounds 3 and 8.
Conclusion: The overall results of the present investigation provided evidence that the crude extract of D. mannii
as well as some of its compounds such compounds 3 and 8 could be a potential source of natural antimicrobial
products.Background
Many plant species of the genus Dorstenia (Moraceae)
are used for medicinal purposes in Africa, Middle East,
Central and South America. African Dorstenia species
has yielded a variety of mono-, di-, and triprenylated and
also mono- and digeranylated flavonoids with interesting
pharmacological properties [1-4]. Dorstenia mannii
Hook f. (Moraceae) is a perennial herb growing in the
tropical rain forest of West Africa [5]. A decoction of* Correspondence: armkuete@yahoo.fr; kuetevictor@yahoo.fr
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reproduction in any medium, provided the orthe leaves is used for the treatment of many diseases,
but mainly for rheumatism and stomach disorders [6].
There are few pharmacological studies reported on D.
mannii. However, prenylated flavonoids isolated from D.
mannii such as 6,8-diprenyleriodictyol (5), dorsmanin C
(3) and dorsmanin F (7) were found to be potent scaven-
gers of the stable free radical 1,1-diphenyl-2-picrylhydra-
zyl [7]. Compounds 3, 5 and 7 also inhibited Cu2
+-mediated oxidation of human low density lipoprotein
[7]. In our continuous search of bioactive compounds
from the genus Dorstenia, the present work was
designed to evaluate the antimicrobial potency of the
methanol extract and compounds isolated from D.
mannii.ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Plant material and extraction
The twigs of Dorstenia mannii Hook. f. were collected at
Nkoljobe mountain, Yaounde, Center region of Camer-
oon in March 2008. The plant was identified by Mr. Vic-
tor Nana of the National herbarium (Yaoundé,
Cameroon) where a voucher specimen was deposited
under the reference number 2135/HNC.
The air dried and powdered twigs (1 kg) were
extracted with methanol (MeOH) for 48 h at room
temperature. The extract was then concentrated under
reduced pressure to give 185 g of a brown residue that
constituted the crude extract (DMT).
Chemicals for antimicrobial assay
Chloramphenicol (Sigma-Aldrich, St. Quentin Fallavier,
France) and Nystatin (Sigma-Aldrich) were used as
reference antibiotics (RA) respectively against bacteria
and Candida albicans. p-Iodonitrotetrazolium chloride
(INT, Sigma-Aldrich) was used as microbial growth indi-
cator [8,9]. Ciprofloxacin and isoniazid (INH) (Sigma)
were used as reference antibiotics (RA) for M. smegmatis
and M. tuberculosis respectively. The isolation and iden-
tification of compounds 1 to 9 from DMT were con-
ducted as previously described [10-12]. The chemical
structures of the isolated compounds are illustrated in
Figure 1.
Antimicrobial assays
Microbial strains and culture media
The studied microorganisms included strains of Provi-
dencia stuartii, Pseudomonas aeruginosa, Klebsiella
pneumoniae, Enterobacter aerogenes, Escherichia coli,
Candida albicans four Mycobacteria namely M. smeg-
matis, drug-susceptible strain of M. tuberculosis H37Rv
obtained from the American Type Culture Collection,
and two clinical strains of M. tuberculosis MTCS1,
MTCS2. M. smegmatis was cultured on Middlebrook
7 H11 agar and allowed to grow for 24 h. M. tuberculosis
was plated on Löwenstein–Jensen medium and allowed
to grow for 3–4 weeks at 37°C. Middlebrook 7 H9 broth
was used to determine the MIC and MMC values of the
test samples on M. smegmatis and M. tuberculosis. Nu-
trient Agar and Sabouraud Glucose Agar were used for
the activation of Gram-negative bacteria and fungi re-
spectively [13]. The clinical strains used in this work are
our Laboratory collection previously obtained from
Yaoundé General Hospital (Cameroon), and from the
Mediterranean University (Marseille, France).
INT colorimetric assay for MIC and MMC determinations
The MIC determinations on M. smegmatis, fungi, and
Gram-negative bacteria were conducted using rapid INTcolorimetric assay according to previously described
methods [8,9] with some modifications. The test samples
and RA were first of all dissolved in DMSO/MHB or
DMSO/7 H9 broth. The final concentration of DMSO
was lower than 2.5% and does not affect the microbial
growth [14]. The solution obtained was then added to
7 H9 broth (M. smegmatis) or MHB (other organisms),
and serially diluted two fold (in a 96- wells microplate).
100 μl of inoculum 1.5 x 106 CFU/ml prepared in appro-
priate broth was then added [15]. The plates were cov-
ered with a sterile plate sealer, then agitated to mix the
contents of the wells using a plate shaker and incubated
at 37°C for 18 h. The assay was repeated thrice. Wells
containing adequate broth, 100 μl of inoculum and
DMSO to a final concentration of 2.5% served as nega-
tive control. The MIC of samples was detected after
18 h incubation at 37°C, following addition (40 μl) of
0.2 mg/ml p-iodonitrotetrazolium chloride (INT) and in-
cubation at 37°C for 30 minutes. Viable bacteria reduced
the yellow dye to a pink. MIC was defined as the sample
concentration that prevented this change and exhibited
complete inhibition of microbial growth. The MMC was
determined by adding 50 μl aliquots of the preparations,
which did not show any growth after incubation during
MIC assays, to 150 μl of adequate broth. These prepara-
tions were incubated at 37°C for 48 h. The MMC was
regarded as the lowest concentration of extract, which
did not produce a color change after addition of INT as
mentioned above [14,16].
Microplate Alamar Blue assay against M. tuberculosis
The activity of all samples against M. tuberculosis strains
was tested using the MABA [17]. Briefly, each of the
above M. tuberculosis strains was cultured at 37°C in
Middlebrook 7 H9 broth supplemented with 0.2% gly-
cerol and 10% Oleic Acid–Albumin–Dextrose–Catalase
(Sigma) until logarithmic growth was reached. About
6x106 CFU/ml inoculum of M. tuberculosis was then
added to the two fold serially diluted samples. The final
concentration of DMSO in all assays was 2.5% or less
and this dilution also served as solvent control. The
samples were assayed in triplicate. All tests were carried
out in sterile flat-bottomed 96-well microplates. Each
microplate was incubated for 5 days at 37°C in a 5%
CO2 atmosphere in a sealed plastic CO2-permeable bag.
After 5 days of incubation, 32 μl of a mixture of freshly
prepared Alamar Blue solution and 20% sterile Tween-
80 (Sigma) 1:1 v/v were added to one growth-control
well. The microplates were incubated again at 37°C for
24 h. If a color shift from blue to pink was observed in
the growth-control sample, 32 μl of alamar blue solution
was added to each of the remaining wells, and the
microplate was further incubated for 24 h. A well-































































Figure 1 Chemical structures of the compounds isolated from the twigs of Dortenia mannii. Dorsmanins A(1), B(2), C(3), D(4), E (6), F (7), G
(8), I (9) and 6,8 diprenyleriodictyol (5).
Mbaveng et al. BMC Complementary and Alternative Medicine 2012, 12:83 Page 3 of 6
http://www.biomedcentral.com/1472-6882/12/83growth, whereas a blue color indicated an absence of
growth. The MIC corresponded to the greatest dilution
of sample extract in which the color shift from blue to
pink was not observed.
Samples with recorded MIC values following MABA
were assayed for their mycobactericidal effect [17].
Briefly, 5 μl of the undeveloped mycobacterial suspen-
sions were transferred from the former to a new micro-
plate that contained 195 μl of fresh culture medium per
well. Three wells were inoculated with 100 μl of fresh in-
oculum as for MABA and three more wells were incu-
bated with 200 μl of culture medium only, as negative
controls. The microplates were incubated and developed
with alamar blue as for MABA. The MMC corresponded
to the minimum sample concentration that did not
cause a color shift in cultures that were re-incubated in
fresh medium.
Results and discussion
The tested compounds were isolated from DMT and
identified as previously described as dorsmanin A (1), B
(2), C (3), D (4) and 6,8-diprenyleriodictyol (5) [10],dorsmanin E (6), F (7), G (8) [11] and dorsmanin I (9)
[12]. These compounds together with the crude metha-
nol extract were tested for their antimicrobial activities
against bacteria and yeasts and the results are reported
in Tables 1 and 2.
The results of the MIC determinations (Table 1)
demonstrated that the methanol extract as well as com-
pounds 3 and 8 were able to prevent the growth of all
the fourteen studied microorganisms, including myco-
bacteria, yeast and Gram-negative bacteria, within the
concentration range of 4 to 1024 μg/ml. Other com-
pounds showed selective activities, their inhibitory
effects being noted on 12/14 (85.7%) studied pathogens
for compound 7, 7/14 (50%) for compound 6, 6/14
(42.9%) for compounds 9, 5/14 (35.7%) for compounds
2 and 5, 3/14 (21.4%) for compounds 1 and 4. The low-
est MIC value for the methanol extract (64 μg/ml) was
obtained on C. albicans. The lowest value for individual
compounds (4 μg/ml) was recorded with compounds 3
on P. aeruginosa PA01 and 7 on E. coli ATCC strain.
The corresponding values for the RA ranged from 0.5 to
64 μg/ml, P. aeruginosa PA01 and M. tubercolosis
Table 1 Minimal inhibitory concentrations (MIC in μg/ml) of the studied samples and reference antibiotics against the
tested microorganisms
Tested samples* Microorganisms, strains and MIC (μg/ml)
E. coli P. aeruginosaK. pneumoniae E.aerogenes P. stuartiiC. albicansM. smegmatisM. tuberculosis
ATCC10536AG100PA01 PA124 ATCC11296KP55ATCC13048CM64NAE16 ATCC 9002ATCC 700084 ATCC 27294MTCS1MTCS2
DMT 256 512 512 1024 128 512 128 512 128 64 128 128 1024 512
1 512 - - - - - 128 - 128 - - NT NT NT
2 128 128 - - - - - - 1024 - 512 512 - -
3 64 64 4 64 128 64 32 64 16 64 64 32 128 32
4 - - 128 - 512 - - - 1024 - - NT NT NT
5 512 - - - 1024 - 32 - 128 32 - NT NT NT
6 512 128 512 - 128 - 16 - 256 8 - NT NT NT
7 4 256 32 - 8 64 16 - 64 16 128 128 256 128
8 16 128 8 32 128 32 64 32 32 128 64 64 64 64
9 - - - - - - 256 - 256 32 128 256 - 512
RAb 2 8 64 32 8 4 8 4 32 16 0.5 0.5 64 2
aTested samples [DMT: methanol extract from the twigs of Dorstenia mannii; dorsmanins A(1), B(2), C(3), D(4) E(6), F(7), G(8), I (9) and 6,8 diprenyleriodictyol (5);
bRA : reference antibiotics were chloramphenicol for bacteria, nystatin for C. albicans, ciprofloxacin for M. smegmatis, isoniazid for M.tuberculosis; (−):
MIC> 1024 μg/ml
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minations (Table 2) also showed good activities for
some of the tested samples such as compounds 3 and 8.
MMC values not greater than 1024 μg/ml were
recorded on all studied microorganisms with com-
pounds 3 and 8, on 12/14 (85.7%) studied organisms for
compound 7, 9/14 (64.3%) for the crude extract, 4/14Table 2 Minimal microbicidal concentrations (MMC in μg/ml)
the tested microorganisms
Tested samples* Microorganism
E. coli P. aeruginosaK. pneumoniae E.aeroge
ATCC10536AG100PA01 PA124 ATCC11296KP55ATCC13
DMT 512 >10241024 >1024 512 1024 512
1 >1024 ND ND ND ND ND 1024
2 1024 1024 ND ND ND ND ND
3 128 128 8 128 256 128 64
4 ND ND 1024 ND >1024 ND ND
5 >1024 ND ND ND >1024 ND 128
6 >1024 >1024>1024 ND 256 ND 64
7 8 512 64 ND 16 256 32
8 32 512 16 64 256 128 128
9 ND ND ND ND ND ND 1024
RAb 4 32 128 128 32 16 16
aTested samples [DMT: methanol extract from the twigs of Dorstenia mannii; dorsm
bRA : reference antibiotics were chloramphenicol for bacteria, nystatin for C. albican
MIC> 1024 μg/ml; (ND): not determined as MIC was >1024 μg/ml(28.6%) for compound 9, 3/14 (21.4%) for compounds 5
and 6, 2/14 (14.3%) for compounds 1 and 2, 1/14 (7.1%)
for compound 4.
The compounds isolated from D. mannii and tested
herein were all flavonoids. This class of compounds is
very common in the genus Dorstenia [10-12] and their
antimicrobial activities were also reported [2-4]. In theof the studied samples and reference antibiotics against
s, strains and MMC (μg/ml)
nes P. stuartiiC. albicansM. smegmatisM. tuberculosis
048CM64 NAE16 ATCC 9002ATCC 700084 ATCC 27294MTCS1MTCS2
>1024256 128 256 256 >1024>1024
ND 1024 ND ND NT NT NT
ND >1024 ND 512 >1024 ND ND
128 64 128 128 64 256 64
ND >1024 ND ND NT NT NT
ND 1024 64 ND NT NT NT
ND >1024 16 ND NT NT NT
ND 256 32 256 256 1024 512
128 64 256 128 128 128 128
ND >1024 64 1024 512 ND >1024
16 128 32 1 1 128 4
anins A(1), B(2), C(3), D(4) E(6), F(7), G(8), I (9) and 6,8 diprenyleriodictyol (5);
s, ciprofloxacin for M. smegmatis, isoniazid for M.tuberculosis; (−):
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was recorded with the crude extract and compounds
from D. mannii. Phytochemicals are routinely classified
as antimicrobials on the basis of susceptibility tests that
produce MIC in the range of 100 to 1000 μg/ml [18].
Activity is considered to be significant if MIC values are
below 100 μg/ml for crude extract and moderate when
the MIC values vary from 100 to 625 μg/ml [19,20].
Therefore, the activity recorded with the crude extract
on C. albicans can be considered as important. Also,
compounds with significant activities (MIC< 10 μg/ml)
on at least one of the studied organisms include 3, 6, 7
and 8. The MIC values recorded with compounds 3 on
P. aeruginosa PA01, 6 on C. albicans, 7 on P. aeruginosa
PA01 and K. pneumoniae ATCC strain, and C. albicans,
8 on P. aeruginosa PA01, PA124, P. stuartii, M. tubercu-
losis MTCS1 were lower than or equal to those of the
reference drugs, highlighting their interesting activities.
This observation is in consistence with previous work
on flavonoids isolated from the genus Dorstenia. In fact,
isobavachalcone, 4-hydroxylolonchocarpin, kanzonol C,
stipulin, and many other flavonoids isolated from this
genus were reported for their good antimicrobial poten-
cies, with MIC values below 10 μg/ml on several tested
microorganisms [2-4,21]. A Keen look at the MMC
values indicates that most of them are not more than
fourfold their corresponding MICs. This proves that the
killing effects of many tested samples could be expected
on the sensitive strains [22]. The continuous emergence
of multidrug-resistant (MDR) bacteria drastically
reduces the efficacy of our antibiotic armory and, conse-
quently, increases the frequency of therapeutic failure
[23]. MDR Enterobacteriaceae, including K. pneumoniae,
E. aerogenes and E. coli have also been classified as
antimicrobial-resistant organisms of concern in health-
care facilities [24]. Besides, K. pneumoniae KP55 tested
herein was reported to be resistant to most of the com-
monly used antibiotics, showing high levels of resistance
to ampicillin, ceftazidime, and aztreonam with MIC
values up to 512 μg/ml [25]. In addition Pseudomonas
aeruginosa has emerged as one of the most problematic
Gram-negative pathogens, with the alarmingly high anti-
biotics resistance rates [26]. The good activities of com-
pounds 3 and 8 on most of the tested strains belonging
to MDR phenotypes such as E. coli AG100, P. aerugi-
nosa PA124, E. aerogenes CM64, K. pneumoniae KP55 as
observed herein reinforce the hypothesis that these com-
pounds are natural products with interesting antimicro-
bial potencies.
Tuberculosis (TB) is widely expanded in poor coun-
tries with the highest incidence (more than 80% of cases)
occurring in Asia and Africa [27]. Annual incidence of
TB (over 600 cases per 100 000) has been reported in
many sub-Saharan African countries [28]. In this work,only compounds with inhibitory activity on M. smegma-
tis were tested on M. tuberculosis. However, it has been
demonstrated that the sensitivity of M. tuberculosis is
closer to that of M. smegmatis, a non pathogenic micro-
organism [29]. Therefore, this microorganism can be
used for a preliminary study to select samples with po-
tential activity against M. tuberculosis [29]. Hence, the
results obtained herein are in accordance with such
recommendation.
To the best of our knowledge, the antimicrobial activ-
ity of D. mannii as well as that of the isolated com-
pounds is being reported for the first time. However 6,8-
diprenyleridictyol (5) an,dorsmanin F (7) were reported
for their antitrichomonal activities [30].
Conclusion
The data reported herein are very important, taking into
account the medical importance of the studied microor-
ganisms. Hence, the overall results of the present investi-
gation provide evidence that the crude extract of D.
mannii as well as some of its compounds such as com-
pounds 3 and 8 could be considered as interesting nat-
ural antimicrobial products.
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